The distribution of PIK3CA-activating mutations is different in head and neck cancers, with exclusively helical domain C-to-T transitions observed in HPV-positive tumours and a combination of helical domain and kinase domain mutations in HPV-negative tumours [143]. Here, PIK3CA is linked to neoplasm.